Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

279
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
279
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

516
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
516
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

548
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
548
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

341
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
341
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

332
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
332
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

2.6K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytokine profile-guided management of Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): A management algorithm useful for guiding the selection of treatment options.

Allergology international : official journal of the Japanese Society of Allergology·2025
Same author

Recent advances in the diagnosis and treatment of DIHS/DRESS in 2025.

Allergology international : official journal of the Japanese Society of Allergology·2025
Same author

The Neglected Beneficial Role of Sweat in Atopic Dermatitis Is Spotlighted at Last.

The Journal of investigative dermatology·2024
Same author

Improvement of the Ocular Prognosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A National Survey in Japan.

American journal of ophthalmology·2024
Same author

Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus.

JAMA dermatology·2023
Same author

Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms: Predictive Score and Outcomes.

The journal of allergy and clinical immunology. In practice·2023

Related Experiment Video

Updated: Feb 9, 2026

Establishment and Analysis of Tumor Slice Explants As a Prerequisite for Diagnostic Testing
11:00

Establishment and Analysis of Tumor Slice Explants As a Prerequisite for Diagnostic Testing

Published on: November 29, 2018

14.9K

Fixed drug eruption: pathogenesis and diagnostic tests.

Tetsuo Shiohara1

  • 1Department of Dermatology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan. tpshio@ks.kyorin-u.ac.jp

Current Opinion in Allergy and Clinical Immunology
|May 29, 2009
PubMed
Summary

Intraepidermal CD8+ T cells in fixed drug eruptions play a dual role in skin inflammation. These cells can initiate lesions but also help limit immune reactions, offering insights into inflammatory skin diseases.

More Related Videos

The Madagascar Hissing Cockroach as an Alternative Non-mammalian Animal Model to Investigate Virulence, Pathogenesis, and Drug Efficacy
12:21

The Madagascar Hissing Cockroach as an Alternative Non-mammalian Animal Model to Investigate Virulence, Pathogenesis, and Drug Efficacy

Published on: November 24, 2017

11.5K
Cytological Analysis of Spermatogenesis: Live and Fixed Preparations of Drosophila Testes
10:30

Cytological Analysis of Spermatogenesis: Live and Fixed Preparations of Drosophila Testes

Published on: January 20, 2014

30.0K

Related Experiment Videos

Last Updated: Feb 9, 2026

Establishment and Analysis of Tumor Slice Explants As a Prerequisite for Diagnostic Testing
11:00

Establishment and Analysis of Tumor Slice Explants As a Prerequisite for Diagnostic Testing

Published on: November 29, 2018

14.9K
The Madagascar Hissing Cockroach as an Alternative Non-mammalian Animal Model to Investigate Virulence, Pathogenesis, and Drug Efficacy
12:21

The Madagascar Hissing Cockroach as an Alternative Non-mammalian Animal Model to Investigate Virulence, Pathogenesis, and Drug Efficacy

Published on: November 24, 2017

11.5K
Cytological Analysis of Spermatogenesis: Live and Fixed Preparations of Drosophila Testes
10:30

Cytological Analysis of Spermatogenesis: Live and Fixed Preparations of Drosophila Testes

Published on: January 20, 2014

30.0K

Area of Science:

  • Immunology
  • Dermatology
  • Cellular Biology

Background:

  • Fixed drug eruption serves as a model for studying skin inflammation.
  • Skin-resident T cells are key players in inflammatory skin diseases.

Purpose of the Study:

  • To explore the role of intraepidermal CD8+ T cells in fixed drug eruption.
  • To understand their contribution to skin inflammation mechanisms.

Main Methods:

  • Review of existing literature on fixed drug eruption and T cell function.
  • Analysis of the phenotype and function of intraepidermal CD8+ T cells in lesions.

Main Results:

  • Intraepidermal CD8+ T cells with effector-memory phenotype contribute to tissue damage in fixed drug eruption.
  • Activation of these cells triggers lesions, but extensive damage requires additional T cell recruitment.
  • Regulatory T cells influx limits immune reactions, and patch test positivity correlates with CD8+ T cell presence.

Conclusions:

  • Intraepidermal CD8+ T cells possess both protective and destructive capabilities in the skin immune system.
  • Understanding their function is crucial for inflammatory skin disease mechanisms.